Browsing Tag
USFDA Approval
18 posts
Can an FDA approval move the needle for Alembic Pharmaceuticals stock?
Alembic Pharmaceuticals gains USFDA approval for a key injectable in the U.S. Find out how this regulatory win influences its stock, valuations, and pipeline story.
October 18, 2025
Zydus Lifesciences enters $1.09bn prostate cancer drug market with USFDA green light
Zydus Lifesciences gains USFDA approval for Apalutamide Tablets, 60 mg, expanding its oncology generics portfolio. Find out what this means for investors.
March 19, 2025
New drug launch sends Lupin shares soaring to record highs! Find out what’s next
Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch…
September 5, 2024
Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity
Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final…
August 27, 2024
Tentative approval granted to Alembic Pharmaceuticals for pulmonary hypertension treatment by FDA
Alembic Pharmaceuticals Limited has achieved a significant milestone by securing tentative approval from the US Food & Drug…
July 13, 2024
Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets
Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and…
July 4, 2024
Alembic Pharmaceuticals gains FDA approval for Icatibant Injection
Alembic Pharmaceuticals Limited has achieved a significant milestone with the US Food & Drug Administration’s (USFDA) final approval…
June 18, 2024
Gland Pharma gains FDA approval for Edaravone Injection, set to treat ALS
Gland Pharma Limited, a prominent player in the generic injectable-focused pharmaceutical industry, has received approval from the United…
May 7, 2024
Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market
Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following…
April 23, 2024
Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders
Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by…
April 9, 2024